Strategy

Inion’s mission  is to be the leading company focused on the development and successful commercialisation of innovative and unique biodegradable and bioactive surgical implants in selected high-value orthopaedic markets.

Inion believes strongly in the potential of its core biodegradable technologies to develop commercially attractive products that offer significant benefits to patients, surgeons and distributors. The Company also believes that as the market acceptance and use of such implants increases, they will gradually replace traditional materials (metals) where appropriate, and that this represents a major commercial opportunity.

Market Focus

Inion is focusing its product offering in two key areas: Spine surgery and Specialty Orthopaedics (targeting foot and ankle, and injuries to the upper extremity, i.e. hand, wrist and elbow).

These segments are attractive to Inion as they are high-value, have an increasing acceptance of innovation and therefore have a high growth potential for biodegradable implants. Furthermore, there are clear and established channels to customers, which Inion intends to exploit as it strategically grows its product portfolio targeting these areas in order to capture a greater share of these important market segments.

Distribution Strategy

Inion’s priority market is the USA where it is building a network of specialist independent local distributors to access customers.

For select markets in Europe and the Rest of the World, Inion is developing its distribution network with established orthopaedic-focused distributors with excellent local relationships

New Product Development

Near-term value will be created by new product development in its target segments of Spine and Specialty Orthopaedics.

Further product development will be determined through consultation with key opinion leaders in their respective fields and rigorous market analysis to validate the commercial opportunity.

Research & Development

Inion maintains a strong focus on R&D, which is strongly aligned with its commercial objectives.
Inion’s longer-term R&D focus is on developing next-generation bioactive biomaterials that offer a significant clinical benefit through accelerated bone growth.

Building a Strong Organisation

In order to successfully drive its commercial strategy in its target markets, Inion has built a strong and commercially focused senior management team, supported by an experienced Board of Directors, and an aligned and motivated organisation.